USPTO serial 86225611
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martha J. Engel
MARTHA J. ENGEL WINTHROP & WEINSTINE, P.A.225 S 6TH STMINNEAPOLIS, MN 55402-4601UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment of diabetes, arteriosclerosis, cancer, cancer metastasis, high blood pressure, skin disease, arthritis, asthma, and allergy; medical diagnostic reagents; reagents for medical and clinical diagnostic purposes; diagnostic preparations for medical purposes; medical and veterinary reagents for use in medical genetic testing; reagents comprising gene chips used for clinical diagnosis for medical and diagnostic purposes; medical diagnostic reagents used for diagnosing certain diseases by analyzing the patterns of gene expression with DNA chips and protein chips; medical and veterinary diagnostic reagent kits for immunodiagnosis comprising gene and protein for medical and veterinary use; clinical medical and veterinary reagents for genetic detection of food poisoning bacteria; chemical reagents for medical and veterinary purposes; analytical reagents for medical purposes; medical reagents for analyzing components of body fluids, blood and urine; medical diagnostic reagents for urine analysis; medical diagnostic reagents for blood analysis; medical diagnostic reagents for analyzing electrolyte in body fluid; medical diagnostic reagents for immunoassay analysis; medical diagnostic reagents for measuring glucose; medical diagnostic reagents for measuring glycohemoglobin; medical diagnostic reagents for measuring ammonia; medical diagnostic test strips for urine analysis; medical diagnostic test strips for blood analysis | ACTIVE | — |
| 009 | laboratory devices for genetic testing, namely, for detecting genetic sequences; electronic products for the analysis of optical signals, namely, optical analyzers; food analyzers for measuring of nutritional components and the amount of pesticide residue in food; electronic publications in the nature of slide shows in the field of medical education; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids | ACTIVE | — |
| 010 | medical apparatus and instruments, namely, medical diagnostic instruments for the analysis of body fluids and parts therefor; blood analyzers for medical purposes and parts therefor; automated biochemical analyzers for medical purposes and parts therefor; diagnostic apparatus for urine analysis for the detection of diabetes and parts therefor; medical apparatus for measuring glycated hemoglobin and parts therefor; medical apparatus for determining osmotic pressure and parts therefor; blood gas analyzers for medical purposes and parts therefor; medical apparatus for drawing blood samples; blood glucose meters and parts therefor; sensors for monitoring blood glucose level as part of blood glucose meters; medical apparatus for drawing blood, namely, puncture apparatus and parts for positioning of puncture; lancets; lancets for blood drawing; surgical apparatus and instruments for medical, dental, and veterinary use; veterinary apparatus and instruments, namely, veterinary diagnostic apparatus and instruments for analyzing blood, urine, and other bodily fluids; devices for monitoring blood glucose for medical purposes; carrying case specifically adapted for carrying diabetic supplies, namely, blood glucose meter, testing strips and also including insulin and other related apparatus | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2014 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 8, 2014 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 12, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 22, 2014 | NWAP | NEW APPLICATION ENTERED | — |